Welcome to our dedicated page for ReWalk Robotics Ltd. news (Ticker: RWLK), a resource for investors and traders seeking the latest updates and insights on ReWalk Robotics Ltd. stock.
ReWalk Robotics Ltd. (formerly Argo Medical Technologies) is a pioneering company in the field of wearable robotic exoskeletons. Established in 2001, ReWalk aims to revolutionize the health and life experiences of individuals with spinal cord injury (SCI). Headquartered in the United States, Israel, and Germany, the company is committed to enhancing mobility and wellness for individuals with neurological conditions.
Core Business: ReWalk designs, develops, and markets innovative exoskeletons. The company's flagship product, the ReWalk exoskeleton, enables individuals with SCI to stand upright and walk by providing powered hip and knee motion. As the only exoskeleton with FDA clearance for personal use, ReWalk has been extensively tested in the U.S., Europe, and Israel, supported by the most published data in the rehabilitation market.
Recent Achievements: Recently, ReWalk supported the
Rhea-AI Summary
ReWalk Robotics (DBA Lifeward™), a global leader in assistive technologies, applauds the introduction of a Senate companion bill to H.R. 6373, the VA Spinal Trauma Access to New Devices (STAND) Act. The legislation aims to provide annual examinations and assessments for assistive technologies, including Personal Exoskeletons, for Veterans with Spinal Cord Injury, increasing access to life-changing solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
ReWalk Robotics Ltd. (LFWD) announces a 1-for-7 reverse split to meet Nasdaq listing standards. The split aims to increase share price above $1.00 while reducing outstanding shares. The split will apply to warrants and stock options, with issued shares decreasing from 60.1 million to 8.6 million post-split.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Two recent research publications highlight the effectiveness of the ReStore Exo-Suit in improving walking ability for post-stroke patients. The studies show significant improvements in walking speed and distance, emphasizing the clinical value of Lifeward's technology for rehabilitation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: LFWD) announced a deferral in pricing decision for personal exoskeletons by CMS, with payment determination on a case-by-case basis until finalized. Lifeward has provided 35 exoskeletons to Medicare beneficiaries to support demand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
ReWalk Robotics Ltd. (DBA Lifeward) reported record annual revenue of $13.9 million in 2023, a 151% increase from 2022. The integration of commercial and operational resources led to $3 million in annual net savings. The company unveiled its new branding as Lifeward and benefitted from CMS including exoskeletons in the Medicare brace benefit category. Fourth-quarter revenue was $6.9 million, up 216% from 2022, with a gross margin of 35.5%. Operating expenses were $8.6 million, resulting in an operating loss of $6.1 million. Net loss was $5.6 million. The company had $28.1 million in cash and expects 2024 revenue between $28 to $32 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
News
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: LFWD) to release fourth quarter and fiscal year-end 2023 financial results on February 27, 2024. Conference call with CEO and CFO to discuss financial results. Webcast available on GoLifeward.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
ReWalk Robotics Ltd. rebrands as Lifeward, unveiling a new name, stock ticker, logo, website, and corporate messaging. The company aims to empower individuals facing physical limitations or disabilities by delivering innovative solutions like the AlterG Anti-Gravity systems. The rebrand reflects the broader goal of elevating the standard of care in rehabilitation and driving growth through a unified commercial team. The new stock ticker 'LFWD' will be effective from January 30, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: RWLK) is expanding its direct sales coverage to Canada following the integration of the former ReWalk and AlterG commercial teams. The company anticipates increased sales force capacity and plans to penetrate underserved markets with its innovative technologies for individuals with neurological conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.85%
Tags
-
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: RWLK) will present at the Sidoti January Virtual Investor Conference on January 17-18, 2024. CEO Larry Jasinski and CFO Mike Lawless will provide an overview presentation and host one-on-one meetings with investors. Interested investors can register for the presentation or one-on-ones at www.sidoti.com/events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.85%
Tags
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: RWLK) announced that it has received payment from Noridian Healthcare Solutions for its first claim for the ReWalk Personal Exoskeleton, marking coverage and payment by Medicare fee-for-service for the first-ever claim submitted for a ReWalk Personal Exoskeleton device. This milestone reflects an acknowledgement by Medicare that the ReWalk Personal Exoskeleton is a medically necessary device, as supported by a body of scientific evidence, when prescribed for an eligible Medicare beneficiary with spinal cord injury. The 2024 Home Health Rule, which codifies a clear coverage pathway for personal exoskeletons, has gone into effect on January 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.57%
Tags
FAQ
What is the market cap of ReWalk Robotics Ltd. (RWLK)?
The market cap of ReWalk Robotics Ltd. (RWLK) is approximately 8.9M.
ReWalk Robotics Ltd.